Implementing a patient-centred and evidence-based intervention to reduce BEnzodiazepine and sedative-hypnotic use to improve patient SAFEty and quality of care

Información del proyecto

BE-SAFE

Identificador del acuerdo de subvención: 101057123

DOI

10.3030/101057123

Fecha de la firma de la CE 18 Mayo 2022

Fecha de inicio 1 Septiembre 2022

Fecha de finalización 31 Agosto 2027

Financiado con arreglo a

• Health

Coste total

€ 4 883 232,00

Aportación de la UE

€ 4 883 229,00

Coordinado por

UNIVERSITE CATHOLIQUE DE LOUVAIN
Belgium

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

Websites, patent fillings, videos etc. (3)

Information material for the public

Comprehensive set of information material related to overuse of BSH for the public

BE-SAFE podcasts online

Collection of Podcasts files tackling key topics related BSH addressed health professionals and general public

Public website

Public website up and running to centralise BE-SAFE products

Documents, reports (3)

Clinical pathways and healthcare systems

Current key clinical pathways (or care trajectories) in relation to BSH reduction identified and described in the six participating European countries

Guidelines to reduce BSHs

Trustworthy guidelines to reduce BSHs published on MAGICapp website and BE-SAFE portal

Barriers and enablers to reduce BSHs

Report of the survey, presenting the barriers and enablers to discontinuing BSHs among patients, informal carers and health care professionals in the six European countries

Publicaciones

Peer reviewed articles (6)

Comparative effectiveness of interventions to facilitate deprescription of benzodiazepines and other sedative hypnotics: systematic review and meta-analysis

Autores: Dena Zeraatkar, Sumanth Kumbargere Nagraj, Michael Ling, Tanvir Jassal, Sarah Kirsh, João Pedro Lima, Tyler Pitre, Rachel Couban, Muizz Hussain, Siri Seterelv, Stijn Van de Velde, Katarzyna Gustavsson, Adam Wichniak, Carole E Aubert, Antoine Christiaens, Anne Spinewine, Thomas Agoritsas
Publicado en: BMJ, Edición 389, 2025, ISSN 1756-1833
Editor: BMJ
DOI: 10.1136/BMJ-2024-081336

Development and validation of the medical attitudes towards deprescribing questionnaire: comment

Autores: Vladyslav Shapoval; Andrea M. Patey; Séverine Henrard; Anne Spinewine
Publicado en: Internal and Emergency Medicine, 2024, ISSN 1970-9366
Editor: SIMI
DOI: 10.1007/S11739-024-03675-8

Equipping physicians for benzodiazepine receptor agonists deprescription in older adults: theory-based development of the BE-SAFE intervention

Autores: François-Xavier Sibille, Joanna Salbert, Lucy Bolt, Vagioula Tsoutsi, Enrico Callegari, Olivia Dalleur, Tokandji Adda, Thomas Agoritsas, Thomas Berger, Carole E. Aubert, Dimitris Dikeos, Antoni Salvà, Begoña Pascual, Ramon Miralles, Torgeir Bruun Wyller, Andrea M. Patey, Jeremy M. Grimshaw, Adam Wichniak, Anne Spinewine, Marie de Saint Hubert
Publicado en: Research in Social and Administrative Pharmacy, Edición 21, 2025, ISSN 1551-7411
Editor: Elsevier BV
DOI: 10.1016/J.SAPHARM.2025.05.002

Barriers to Deprescribing Benzodiazepines in Older Adults in a Survey of European Physicians

Autores: Vladyslav Shapoval, Marie de Saint Hubert, Perrine Evrard, François-Xavier Sibille, Carole E. Aubert, Lucy Bolt, Vagioula Tsoutsi, Pinelopi Kollia, Antoni Salvà, Ramon Miralles, Adam Wichniak, Katarzyna Gustavsson, Torgeir Bruun Wyller, Enrico Callegari, Jeremy M. Grimshaw, Justin Presseau, Séverine Henrard, Anne Spinewine
Publicado en: JAMA Network Open, Edición 8, 2025, ISSN 2574-3805
Editor: American Medical Association (AMA)
DOI: 10.1001/JAMANETWORKOPEN.2024.59883

Deprescribing benzodiazepine receptor agonists for insomnia in older adults

Autores: Antoine Christiaens, Carole E Aubert, Adam Wichniak, Antoni Salvà Casanovas, Anne Spinewine
Publicado en: The Lancet, Edición 402, 2023, ISSN 0140-6736
Editor: Elsevier BV
DOI: 10.1016/S0140-6736(23)01562-3

Barriers to and Enablers of Supporting Deprescribing Benzodiazepines in Older Adults: A Survey of European Nonphysician Healthcare Professionals

Autores: Vladyslav Shapoval, Perrine Evrard, François‐Xavier Sibille, María López‐Toribio, Olivia Dalleur, Carole E. Aubert, Lucy Bolt, Vagioula Tsoutsi, Maria Ntafouli, Laura Fernández Maldonado, Ramon Miralles, Adam Wichniak, Katarzyna Gustavsson, Torgeir Bruun Wyller, Enrico Callegari, Jeremy M. Grimshaw, Justin Presseau, Séverine Henrard, Anne Spinewine
Publicado en: Basic & Clinical Pharmacology & Toxicology, Edición 137, 2025, ISSN 1742-7835
Editor: Wiley
DOI: 10.1111/BCPT.70100

Other (1)

Guideline - BE-SAFE: Deprescription of benzodiazepine and sedative hypnotics (BSHs) in insomnia disorder

Autores: Thomas Agoritsas; Sumanth Kumbargere Nagraj; Enrico Callegari; Minna Johansson
Publicado en: 2023
Editor: MAGIC Evidence Ecosystem Foundation